Global Respiratory Disease Testing/Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 289015
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Respiratory Disease Testing/Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Respiratory Disease Testing/Diagnostics market size is estimated to be worth US$ 4661.5 million in 2021 and is forecast to a readjusted size of USD 5278.1 million by 2028 with a CAGR of 1.8% during review period. Hospitals accounting for % of the Respiratory Disease Testing/Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Imaging Test segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Respiratory Disease Testing/Diagnostics include Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, and Fischer and Paykel, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Respiratory Disease Testing/Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Imaging Test

Respiratory Measurement

Blood Gas Test

Other

Market segment by Application, can be divided into

Hospitals

Physician Clinics

Clinical Laboratories

Other

Market segment by players, this report covers

Becton Dickinson

Abbott Laboratories

Abbott

Cepheid

Fischer and Paykel

Futuremed

Hoffmann-La Roche

Instrumentation Laboratories

Medtronic

NDD Medical Technologies

Nihon Kohden

Philips Medical Systems

SDI Diagnostics

Seegene

Smiths Medical

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Respiratory Disease Testing/Diagnostics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Respiratory Disease Testing/Diagnostics, with revenue, gross margin and global market share of Respiratory Disease Testing/Diagnostics from 2019 to 2022.

Chapter 3, the Respiratory Disease Testing/Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Respiratory Disease Testing/Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Respiratory Disease Testing/Diagnostics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Respiratory Disease Testing/Diagnostics

1.2 Classification of Respiratory Disease Testing/Diagnostics by Type

1.2.1 Overview: Global Respiratory Disease Testing/Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Type in 2021

1.2.3 Imaging Test

1.2.4 Respiratory Measurement

1.2.5 Blood Gas Test

1.2.6 Other

1.3 Global Respiratory Disease Testing/Diagnostics Market by Application

1.3.1 Overview: Global Respiratory Disease Testing/Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Physician Clinics

1.3.4 Clinical Laboratories

1.3.5 Other

1.4 Global Respiratory Disease Testing/Diagnostics Market Size & Forecast

1.5 Global Respiratory Disease Testing/Diagnostics Market Size and Forecast by Region

1.5.1 Global Respiratory Disease Testing/Diagnostics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Respiratory Disease Testing/Diagnostics Market Size by Region, (2017-2022)

1.5.3 North America Respiratory Disease Testing/Diagnostics Market Size and Prospect (2017-2028)

1.5.4 Europe Respiratory Disease Testing/Diagnostics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Respiratory Disease Testing/Diagnostics Market Size and Prospect (2017-2028)

1.5.6 South America Respiratory Disease Testing/Diagnostics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Respiratory Disease Testing/Diagnostics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Respiratory Disease Testing/Diagnostics Market Drivers

1.6.2 Respiratory Disease Testing/Diagnostics Market Restraints

1.6.3 Respiratory Disease Testing/Diagnostics Trends Analysis

2 Company Profiles

2.1 Becton Dickinson

2.1.1 Becton Dickinson Details

2.1.2 Becton Dickinson Major Business

2.1.3 Becton Dickinson Respiratory Disease Testing/Diagnostics Product and Solutions

2.1.4 Becton Dickinson Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Becton Dickinson Recent Developments and Future Plans

2.2 Abbott Laboratories

2.2.1 Abbott Laboratories Details

2.2.2 Abbott Laboratories Major Business

2.2.3 Abbott Laboratories Respiratory Disease Testing/Diagnostics Product and Solutions

2.2.4 Abbott Laboratories Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Abbott Laboratories Recent Developments and Future Plans

2.3 Abbott

2.3.1 Abbott Details

2.3.2 Abbott Major Business

2.3.3 Abbott Respiratory Disease Testing/Diagnostics Product and Solutions

2.3.4 Abbott Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Abbott Recent Developments and Future Plans

2.4 Cepheid

2.4.1 Cepheid Details

2.4.2 Cepheid Major Business

2.4.3 Cepheid Respiratory Disease Testing/Diagnostics Product and Solutions

2.4.4 Cepheid Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Cepheid Recent Developments and Future Plans

2.5 Fischer and Paykel

2.5.1 Fischer and Paykel Details

2.5.2 Fischer and Paykel Major Business

2.5.3 Fischer and Paykel Respiratory Disease Testing/Diagnostics Product and Solutions

2.5.4 Fischer and Paykel Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Fischer and Paykel Recent Developments and Future Plans

2.6 Futuremed

2.6.1 Futuremed Details

2.6.2 Futuremed Major Business

2.6.3 Futuremed Respiratory Disease Testing/Diagnostics Product and Solutions

2.6.4 Futuremed Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Futuremed Recent Developments and Future Plans

2.7 Hoffmann-La Roche

2.7.1 Hoffmann-La Roche Details

2.7.2 Hoffmann-La Roche Major Business

2.7.3 Hoffmann-La Roche Respiratory Disease Testing/Diagnostics Product and Solutions

2.7.4 Hoffmann-La Roche Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Hoffmann-La Roche Recent Developments and Future Plans

2.8 Instrumentation Laboratories

2.8.1 Instrumentation Laboratories Details

2.8.2 Instrumentation Laboratories Major Business

2.8.3 Instrumentation Laboratories Respiratory Disease Testing/Diagnostics Product and Solutions

2.8.4 Instrumentation Laboratories Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Instrumentation Laboratories Recent Developments and Future Plans

2.9 Medtronic

2.9.1 Medtronic Details

2.9.2 Medtronic Major Business

2.9.3 Medtronic Respiratory Disease Testing/Diagnostics Product and Solutions

2.9.4 Medtronic Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Medtronic Recent Developments and Future Plans

2.10 NDD Medical Technologies

2.10.1 NDD Medical Technologies Details

2.10.2 NDD Medical Technologies Major Business

2.10.3 NDD Medical Technologies Respiratory Disease Testing/Diagnostics Product and Solutions

2.10.4 NDD Medical Technologies Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 NDD Medical Technologies Recent Developments and Future Plans

2.11 Nihon Kohden

2.11.1 Nihon Kohden Details

2.11.2 Nihon Kohden Major Business

2.11.3 Nihon Kohden Respiratory Disease Testing/Diagnostics Product and Solutions

2.11.4 Nihon Kohden Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Nihon Kohden Recent Developments and Future Plans

2.12 Philips Medical Systems

2.12.1 Philips Medical Systems Details

2.12.2 Philips Medical Systems Major Business

2.12.3 Philips Medical Systems Respiratory Disease Testing/Diagnostics Product and Solutions

2.12.4 Philips Medical Systems Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Philips Medical Systems Recent Developments and Future Plans

2.13 SDI Diagnostics

2.13.1 SDI Diagnostics Details

2.13.2 SDI Diagnostics Major Business

2.13.3 SDI Diagnostics Respiratory Disease Testing/Diagnostics Product and Solutions

2.13.4 SDI Diagnostics Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 SDI Diagnostics Recent Developments and Future Plans

2.14 Seegene

2.14.1 Seegene Details

2.14.2 Seegene Major Business

2.14.3 Seegene Respiratory Disease Testing/Diagnostics Product and Solutions

2.14.4 Seegene Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Seegene Recent Developments and Future Plans

2.15 Smiths Medical

2.15.1 Smiths Medical Details

2.15.2 Smiths Medical Major Business

2.15.3 Smiths Medical Respiratory Disease Testing/Diagnostics Product and Solutions

2.15.4 Smiths Medical Respiratory Disease Testing/Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Smiths Medical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Respiratory Disease Testing/Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Respiratory Disease Testing/Diagnostics Players Market Share in 2021

3.2.2 Top 10 Respiratory Disease Testing/Diagnostics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Respiratory Disease Testing/Diagnostics Players Head Office, Products and Services Provided

3.4 Respiratory Disease Testing/Diagnostics Mergers & Acquisitions

3.5 Respiratory Disease Testing/Diagnostics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Respiratory Disease Testing/Diagnostics Revenue and Market Share by Type (2017-2022)

4.2 Global Respiratory Disease Testing/Diagnostics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Application (2017-2022)

5.2 Global Respiratory Disease Testing/Diagnostics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2028)

6.2 North America Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2028)

6.3 North America Respiratory Disease Testing/Diagnostics Market Size by Country

6.3.1 North America Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2028)

6.3.2 United States Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

6.3.3 Canada Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

6.3.4 Mexico Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2028)

7.2 Europe Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2028)

7.3 Europe Respiratory Disease Testing/Diagnostics Market Size by Country

7.3.1 Europe Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2028)

7.3.2 Germany Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

7.3.3 France Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

7.3.5 Russia Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

7.3.6 Italy Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2028)

8.2 Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2028)

8.3 Asia-Pacific Respiratory Disease Testing/Diagnostics Market Size by Region

8.3.1 Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Region (2017-2028)

8.3.2 China Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

8.3.3 Japan Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

8.3.4 South Korea Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

8.3.5 India Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

8.3.7 Australia Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2028)

9.2 South America Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2028)

9.3 South America Respiratory Disease Testing/Diagnostics Market Size by Country

9.3.1 South America Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2028)

9.3.2 Brazil Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

9.3.3 Argentina Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2028)

10.2 Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2028)

10.3 Middle East & Africa Respiratory Disease Testing/Diagnostics Market Size by Country

10.3.1 Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2028)

10.3.2 Turkey Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

10.3.4 UAE Respiratory Disease Testing/Diagnostics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Respiratory Disease Testing/Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Respiratory Disease Testing/Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Respiratory Disease Testing/Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Respiratory Disease Testing/Diagnostics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Region (2023-2028)

Table 6. Becton Dickinson Corporate Information, Head Office, and Major Competitors

Table 7. Becton Dickinson Major Business

Table 8. Becton Dickinson Respiratory Disease Testing/Diagnostics Product and Solutions

Table 9. Becton Dickinson Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Laboratories Major Business

Table 12. Abbott Laboratories Respiratory Disease Testing/Diagnostics Product and Solutions

Table 13. Abbott Laboratories Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Abbott Corporate Information, Head Office, and Major Competitors

Table 15. Abbott Major Business

Table 16. Abbott Respiratory Disease Testing/Diagnostics Product and Solutions

Table 17. Abbott Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Cepheid Corporate Information, Head Office, and Major Competitors

Table 19. Cepheid Major Business

Table 20. Cepheid Respiratory Disease Testing/Diagnostics Product and Solutions

Table 21. Cepheid Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Fischer and Paykel Corporate Information, Head Office, and Major Competitors

Table 23. Fischer and Paykel Major Business

Table 24. Fischer and Paykel Respiratory Disease Testing/Diagnostics Product and Solutions

Table 25. Fischer and Paykel Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Futuremed Corporate Information, Head Office, and Major Competitors

Table 27. Futuremed Major Business

Table 28. Futuremed Respiratory Disease Testing/Diagnostics Product and Solutions

Table 29. Futuremed Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 31. Hoffmann-La Roche Major Business

Table 32. Hoffmann-La Roche Respiratory Disease Testing/Diagnostics Product and Solutions

Table 33. Hoffmann-La Roche Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Instrumentation Laboratories Corporate Information, Head Office, and Major Competitors

Table 35. Instrumentation Laboratories Major Business

Table 36. Instrumentation Laboratories Respiratory Disease Testing/Diagnostics Product and Solutions

Table 37. Instrumentation Laboratories Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Medtronic Corporate Information, Head Office, and Major Competitors

Table 39. Medtronic Major Business

Table 40. Medtronic Respiratory Disease Testing/Diagnostics Product and Solutions

Table 41. Medtronic Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. NDD Medical Technologies Corporate Information, Head Office, and Major Competitors

Table 43. NDD Medical Technologies Major Business

Table 44. NDD Medical Technologies Respiratory Disease Testing/Diagnostics Product and Solutions

Table 45. NDD Medical Technologies Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Nihon Kohden Corporate Information, Head Office, and Major Competitors

Table 47. Nihon Kohden Major Business

Table 48. Nihon Kohden Respiratory Disease Testing/Diagnostics Product and Solutions

Table 49. Nihon Kohden Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Philips Medical Systems Corporate Information, Head Office, and Major Competitors

Table 51. Philips Medical Systems Major Business

Table 52. Philips Medical Systems Respiratory Disease Testing/Diagnostics Product and Solutions

Table 53. Philips Medical Systems Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. SDI Diagnostics Corporate Information, Head Office, and Major Competitors

Table 55. SDI Diagnostics Major Business

Table 56. SDI Diagnostics Respiratory Disease Testing/Diagnostics Product and Solutions

Table 57. SDI Diagnostics Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Seegene Corporate Information, Head Office, and Major Competitors

Table 59. Seegene Major Business

Table 60. Seegene Respiratory Disease Testing/Diagnostics Product and Solutions

Table 61. Seegene Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Smiths Medical Corporate Information, Head Office, and Major Competitors

Table 63. Smiths Medical Major Business

Table 64. Smiths Medical Respiratory Disease Testing/Diagnostics Product and Solutions

Table 65. Smiths Medical Respiratory Disease Testing/Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Respiratory Disease Testing/Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Respiratory Disease Testing/Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Respiratory Disease Testing/Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Respiratory Disease Testing/Diagnostics Players Head Office, Products and Services Provided

Table 70. Respiratory Disease Testing/Diagnostics Mergers & Acquisitions in the Past Five Years

Table 71. Respiratory Disease Testing/Diagnostics New Entrants and Expansion Plans

Table 72. Global Respiratory Disease Testing/Diagnostics Revenue (USD Million) by Type (2017-2022)

Table 73. Global Respiratory Disease Testing/Diagnostics Revenue Share by Type (2017-2022)

Table 74. Global Respiratory Disease Testing/Diagnostics Revenue Forecast by Type (2023-2028)

Table 75. Global Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2022)

Table 76. Global Respiratory Disease Testing/Diagnostics Revenue Forecast by Application (2023-2028)

Table 77. North America Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Respiratory Disease Testing/Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Respiratory Disease Testing/Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Respiratory Disease Testing/Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Respiratory Disease Testing/Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Respiratory Disease Testing/Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Respiratory Disease Testing/Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Respiratory Disease Testing/Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Respiratory Disease Testing/Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Respiratory Disease Testing/Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Respiratory Disease Testing/Diagnostics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Respiratory Disease Testing/Diagnostics Picture

Figure 2. Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Type in 2021

Figure 3. Imaging Test

Figure 4. Respiratory Measurement

Figure 5. Blood Gas Test

Figure 6. Other

Figure 7. Respiratory Disease Testing/Diagnostics Revenue Market Share by Application in 2021

Figure 8. Hospitals Picture

Figure 9. Physician Clinics Picture

Figure 10. Clinical Laboratories Picture

Figure 11. Other Picture

Figure 12. Global Respiratory Disease Testing/Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Respiratory Disease Testing/Diagnostics Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Region (2017-2028)

Figure 15. Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Region in 2021

Figure 16. North America Respiratory Disease Testing/Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Respiratory Disease Testing/Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Respiratory Disease Testing/Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Respiratory Disease Testing/Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Respiratory Disease Testing/Diagnostics Market Drivers

Figure 22. Respiratory Disease Testing/Diagnostics Market Restraints

Figure 23. Respiratory Disease Testing/Diagnostics Market Trends

Figure 24. Becton Dickinson Recent Developments and Future Plans

Figure 25. Abbott Laboratories Recent Developments and Future Plans

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Cepheid Recent Developments and Future Plans

Figure 28. Fischer and Paykel Recent Developments and Future Plans

Figure 29. Futuremed Recent Developments and Future Plans

Figure 30. Hoffmann-La Roche Recent Developments and Future Plans

Figure 31. Instrumentation Laboratories Recent Developments and Future Plans

Figure 32. Medtronic Recent Developments and Future Plans

Figure 33. NDD Medical Technologies Recent Developments and Future Plans

Figure 34. Nihon Kohden Recent Developments and Future Plans

Figure 35. Philips Medical Systems Recent Developments and Future Plans

Figure 36. SDI Diagnostics Recent Developments and Future Plans

Figure 37. Seegene Recent Developments and Future Plans

Figure 38. Smiths Medical Recent Developments and Future Plans

Figure 39. Global Respiratory Disease Testing/Diagnostics Revenue Share by Players in 2021

Figure 40. Respiratory Disease Testing/Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 41. Global Top 3 Players Respiratory Disease Testing/Diagnostics Revenue Market Share in 2021

Figure 42. Global Top 10 Players Respiratory Disease Testing/Diagnostics Revenue Market Share in 2021

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 44. Global Respiratory Disease Testing/Diagnostics Revenue Share by Type in 2021

Figure 45. Global Respiratory Disease Testing/Diagnostics Market Share Forecast by Type (2023-2028)

Figure 46. Global Respiratory Disease Testing/Diagnostics Revenue Share by Application in 2021

Figure 47. Global Respiratory Disease Testing/Diagnostics Market Share Forecast by Application (2023-2028)

Figure 48. North America Respiratory Disease Testing/Diagnostics Sales Market Share by Type (2017-2028)

Figure 49. North America Respiratory Disease Testing/Diagnostics Sales Market Share by Application (2017-2028)

Figure 50. North America Respiratory Disease Testing/Diagnostics Revenue Market Share by Country (2017-2028)

Figure 51. United States Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Canada Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Mexico Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Europe Respiratory Disease Testing/Diagnostics Sales Market Share by Type (2017-2028)

Figure 55. Europe Respiratory Disease Testing/Diagnostics Sales Market Share by Application (2017-2028)

Figure 56. Europe Respiratory Disease Testing/Diagnostics Revenue Market Share by Country (2017-2028)

Figure 57. Germany Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. France Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. United Kingdom Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Russia Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Italy Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Asia-Pacific Respiratory Disease Testing/Diagnostics Sales Market Share by Type (2017-2028)

Figure 63. Asia-Pacific Respiratory Disease Testing/Diagnostics Sales Market Share by Application (2017-2028)

Figure 64. Asia-Pacific Respiratory Disease Testing/Diagnostics Revenue Market Share by Region (2017-2028)

Figure 65. China Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Japan Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South Korea Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. India Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Southeast Asia Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Australia Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. South America Respiratory Disease Testing/Diagnostics Sales Market Share by Type (2017-2028)

Figure 72. South America Respiratory Disease Testing/Diagnostics Sales Market Share by Application (2017-2028)

Figure 73. South America Respiratory Disease Testing/Diagnostics Revenue Market Share by Country (2017-2028)

Figure 74. Brazil Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Argentina Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Middle East and Africa Respiratory Disease Testing/Diagnostics Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Respiratory Disease Testing/Diagnostics Sales Market Share by Application (2017-2028)

Figure 78. Middle East and Africa Respiratory Disease Testing/Diagnostics Revenue Market Share by Country (2017-2028)

Figure 79. Turkey Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Saudi Arabia Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. UAE Respiratory Disease Testing/Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source